Micronoma in the News

Translating the Microbiome

Translating the Microbiome

A flurry of microbiome research over the past two decades has led to many insights about the link between the microbes and health, but now the race to the clinic is on. Over the past two decades scientists have been working steadily to unravel the complex interplay of...

How Fungi May Open Up New Doors for Cancer Diagnosis, Treatment

How Fungi May Open Up New Doors for Cancer Diagnosis, Treatment

Experts say fungi can be found in a variety of places in the human body as well as in cancer tumors. Researchers say the microorganisms may be useful in developing new diagnostic tools and treatments. They say fungi may be able to develop biomarkers to detect cancer...

Tumor Associated Fungal Signatures May Offer Diagnostic Insights

Tumor Associated Fungal Signatures May Offer Diagnostic Insights

Fungal communities (mycobiota) constitute a subset of the human microbiome that can trigger an immune response, but little is known about their presence or functional role in human cancers. Two independent studies published in the journal Cell, report converging...

Fungal DNA, Cells Found in Human Tumors

Fungal DNA, Cells Found in Human Tumors

Fungal DNA is present in various types of cancer, according to two studies published yesterday (September 29) in Cell. The findings add support to a hypothesized link between fungi and certain cancers, although researchers emphasize that there isn’t yet evidence for a...

Map of Links between Cancers and Fungi Created

Map of Links between Cancers and Fungi Created

A research team led by the University of California San Diego and the Weizmann Institute of Science in Israel has created an atlas of fungi linked to a range of 35 different cancers for the first time. As reported in the journal Cell, the researchers hope the new...

Leading-Edge Approaches To Early Cancer Detection

Leading-Edge Approaches To Early Cancer Detection

By Deborah Borfitz  September 22, 2022 | Emerging approaches to the early detection of cancer, based on metabolic profiling and microbiome- and exosome-driven liquid biopsies, were highlighted during the recent Next Generation Dx Summit held in Washington, D.C....

These innovative projects are changing the health industry

These innovative projects are changing the health industry

The health category of Fast Company’s World Changing Ideas Awards honors medical innovations that save lives, extend longevity, or increase access to care. See the finalists and honorable mentions below, and read about the winner, the pill that could make routine...

Microbiome Therapeutics Try a Lighter Touch

Microbiome Therapeutics Try a Lighter Touch

The revelation that our commensal bacteria play important roles in health and disease has turned the microbiome into one of the most active frontiers of biomedicine. Yet our efforts to turn our “inner bugs” into drugs have long been limited to investigational fecal...

Could Cancer’s Microbiome Help Diagnose and Treat the Disease?

Could Cancer’s Microbiome Help Diagnose and Treat the Disease?

As a postdoc at the Broad Institute of MIT and Harvard in 2008, cancer biologist Ravid Straussman worked on a collaborative effort to screen normal cells for their influence on cancer cells’ responses to various anticancer therapies. The project turned up hundreds of...

Precision medicine through the cancer microbiome

Precision medicine through the cancer microbiome

With its Oncobiota platform, Micronoma is pioneering the analysis of the cancer microbiome for early cancer detection and creating tools for personalized cancer treatment. Read More

Female Tech Leaders

Female Tech Leaders

Interview with Sandrine Miller-Montgomery, Micronoma, Inc. What are your suggestions to encourage more young women to pursue careers in tech? There are so many facets to working in tech that it is worth considering regardless of being scientific minded or not...the...

Human Blood Harbors Cell-Free Microbial DNA

Human Blood Harbors Cell-Free Microbial DNA

After controlling for high levels of bacterial contamination in their lab and reagents, researchers detect microbial genetic material in plasma samples from healthy people and cancer patients. Read the full article in The Scientist

Micronoma Closes $3.5M Convertible Debt Financing Round

Micronoma Closes $3.5M Convertible Debt Financing Round

Micronoma, a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, closed a $3.5m convertible debt financing round. Read full story.

Microbiome-based diagnostics and biomarkers

Microbiome-based diagnostics and biomarkers

Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine. Read how Micronoma fits in this emerging landscape. Read Article

Prime Time for the Microbiome

Prime Time for the Microbiome

Microbiomics is taking a sharp turn. Until now, the field was limited to fecal transplants from healthy patients to those with gut conditions. The transplant is an awkward procedure that also creates regulatory and other challenges. Read More.

Micronoma Launches with $3 Million Seed Funding

Micronoma Launches with $3 Million Seed Funding

Micronoma, an early cancer-detection biotech that seeks to develop and commercialize a minimally invasive, microbiome-based method, announced today that it has closed a $3 million seed financing round led by microbiome-focused investor, SymBiosis, LLC. Read More.

Start-Up Developing Microbial Cancer Detection Tests

Start-Up Developing Microbial Cancer Detection Tests

13 Aug. 2020. A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples. Micronoma, in San Diego, is also raising $3 million in its seed funding round, equity...

Website Terms of Use, Privacy Policy, and Licenses

Micronoma, INC., CLIA #05D2253538

Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.

Contact Us

If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.

Micronoma
6342 Ferris Square
San Diego, CA 92121